Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial

Overview of attention for article published in The Lancet, January 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

policy: 2 policy sources
twitter: 23 X users
patent: 1 patent

facebook: 1 Facebook page
f1000: 1 research highlight platform

Citations

dimensions_citation: 306 Dimensions

Readers on

mendeley: 235 Mendeley

Summary Policy documents X Patents Facebook Research highlights Dimensions citations

So far, Altmetric has seen 1 public wall post.

Berlin Brandenburger Darmtag, 17 Jan 2013

Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.